Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy

Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy

Non-small cell lung cancer (NSCLC) is a highly malignant tumor, with a significant mortality and morbidity. With the development of tumor immunotherapy, chimeric antigen receptor T cells (CART) gets increasingly attention and achieves prominent contributions in the treatment of hematologic malignanc...

Full description

Bibliographic Details
Main Authors: Xiao-Hong Chen, Ruo Chen, Ming-Yan Shi, Ruo-Fei Tian, Hai Zhang, Zhi-Qian Xin, Zhi-Nan Chen, Ke Wang
Format: Article
Language:English
Published: Elsevier 2022-02-01
Series:Translational Oncology
Subjects:
CART
CD147
NSCLC
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523321003004

Internet

http://www.sciencedirect.com/science/article/pii/S1936523321003004

Similar Items